feed,title,long_url,short_url
Benzinga,"Pfizer Buys 9.9% Stake In CStone, Scores Exclusive Rights To Commercialize Oncological Antibody In China",https://www.benzinga.com/general/biotech/20/09/17710496/pfizer-buys-9-9-stake-in-cstone-scores-exclusive-rights-to-commercialize-oncological-antibody-in-,https://j.mp/2SdD4ie
